<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.0.11" -->
<rss version="0.92">
<channel>
	<title>Medicine Shoppe</title>
	<link>http://medicinehatnews.orly-owl.net</link>
	<description>Medicine Shoppe</description>
	<lastBuildDate>Wed, 14 Oct 2009 02:40:33 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Maderis named to Trinity Bio board</title>
		<description>Former Five Prime Therapeutics executive Gail Maderis joined the board of privately held Trinity Biosystems.  </description>
		<link>http://medicinehatnews.orly-owl.net/7050-maderis-named-to-trinity-bio-board.html</link>
			</item>
	<item>
		<title>Health Science Center leads nationwide study to improve nursing</title>
		<description>The University of Texas Health Science Center at San Antonio has been tapped to work on a national program to help improve the bedside manner of the nation’s nurses.  </description>
		<link>http://medicinehatnews.orly-owl.net/7051-health-science-center-leads-nationwide-study-to-improve-nursing.html</link>
			</item>
	<item>
		<title>HealthPartners, Allina announce collaboration</title>
		<description>HealthPartners and Allina Hospitals &#38; Clinics on Tuesday announced they have entered into a long-term collaboration in the northwest metro that is aimed at providing better and more affordable care for patients.  </description>
		<link>http://medicinehatnews.orly-owl.net/7052-healthpartners-allina-announce-collaboration.html</link>
			</item>
	<item>
		<title>University of Maryland Medical System partners with Civista Medical Center</title>
		<description>The University of Maryland Medical System is taking its health care services down South — to Southern Maryland, that is.  </description>
		<link>http://medicinehatnews.orly-owl.net/7053-university-of-maryland-medical-system-partners-with-civista-medical-center.html</link>
			</item>
	<item>
		<title>Allos raises $93M in stock offer</title>
		<description>Allos Therapeutics Inc. finished selling 14 million shares of stock Tuesday, raising $93 million the biotech drug maker plans to use to market its newly approved drug Folotyn and for general purposes. (ALTH)  </description>
		<link>http://medicinehatnews.orly-owl.net/7054-allos-raises-93m-in-stock-offer.html</link>
			</item>
</channel>
</rss>
